← All trials
NCT04888312
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 17, 2021
- Primary completion
- Feb 28, 2024
- Completion date
- Aug 31, 2025
- First posted
- May 17, 2021
- Last posted
- Oct 4, 2021
- Enrollment
- 80
- Arms / groups
- 1 / —
- Source
- AACT · ingestion pipeline
Sponsors
- Alligator Bioscience ABLead sponsor
- 4Pharma Ltd.Collaborator
- Free University of BrusselsOverall official - principal investigator
- TheradexCollaborator
- Alligator Bioscience ABStudy director
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.